WEBSITE_HTAD Copy of Announcement posters (17)
WEBSITE_HTAD Copy of Announcement posters (12)
WEBSITE_HTAD Copy of Announcement posters (15)
WEBSITE_HTAD Copy of Announcement posters (1)
previous arrow
next arrow

Omnibus HTA Tracker

Check the status of assessments here

Issuances 

20242023202220212020

2023 Issuances

2022 Issuances

2021 Issuances

Latest Assessments


Ongoing Development


Events and Press Releases

CALL FOR PROPOSALS: HTA Research Agenda Program [HTA Research Topics 2024 – Batch 3 (FEC topics and Cycle 1 topics for Economic Assessments and Ethical, Legal, Social, and Health Systems Implication (ELSHI) Assessments)

The Health Technology Assessment (HTA) Philippines invites interested researchers to submit capsule proposals under the HTA Research Agenda Program: 2024 HTA Topics – Batch 3 Call [FEC topics and Cycle 1 topics for Economic Assessments and Ethical, Legal, Social, and Health Systems Implication (ELSHI) Assessments] The following are the health technology topics for economic and...

[FOR PUBLIC CONSULTATION] HTA Council Preliminary Recommendation on Reteplase (10 units lyophilized powder for IV injection) for ST-Elevation Myocardial Infarction (STEMI) Patients

Published on 01 October 2024 As of 23 September 2024, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of Reteplase (10 units lyophilized powder for IV injection) for ST-Elevation Myocardial Infarction (STEMI) Patients for possible inclusion in the Philippine National Formulary (PNF). As such, the HTA Council hereby makes...

STATUS UPDATES ON THE HTA NOMINATIONS FOR CYCLE 3 TOPICS

We would like to inform our stakeholders that the HTA Council will accept nominations only from the Department of Health (DOH) and Philippine Health Insurance Corporation (PhilHealth) in 2024, and open the Call for Nominations to other stakeholders in the 4th quarter of 2025 for Cycle 3 Topics based on the status of ongoing assessments....



Annual Reports